Research Article

Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control

Volume: 19 Number: 4 November 28, 2019
TR EN

Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control

Abstract

Objectives: Type 1 diabetes mellitus (T1DM) is a chronic metabolic disease that is common in childhood. Good metabolic control slows down and even prevents development of diabetes-related micro-vascular complications. Therefore determination of the affecting factors for metabolic control is important. To evaluate effect of at the time of diagnosis demographic, clinical and laboratory characteristics of children and adolescents with T1DM on metabolic control. Materials and Methods: The metabolic control status was evaluated according to the mean hemoglobin A1c (HbA1c) values of the recent one year as good (HbA1c <7.5%), moderate (HbA1c 7.5-9%) and poor (HbA1c >9%). The patient data and the mean HbA1c levels were compared. Results: Data were collected on 144 patients with T1DM. The peak ages at diagnosis were determined to be 4-6 years (21.52%) and 12-14 years (20.83%). The first-degree relatives had the diagnosis of T1DM in 10% of the patients. The mean HbA1c value was determined as 7.7% (7.2-8.8) in girls and 7.8% (7.0-8.6) in boys. Metabolic control was good in 38.19%, moderate in 41.68% and poor in 20.13%. The mean age at diagnosis was 9.13±4.30 years in the patients with good metabolic control and 10.19±4.26 years in patients with poor metabolic control (p=0.252). Metabolic control was found to be better in the patients who had T1DM in the family (p=0.002). Conclusion: Metabolic control was found to be good in patients who had DM in the family. It is thought that patients and their families care about diabetes management after diagnosis, regulate their lifestyle according to diabetes. According to the result, increasing the awareness of diabetes in the family and continuing the motivating trainings for the patients will have a positive effect on the management of diabetes.

Keywords

References

  1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358(9277):221-9.
  2. Diabetes Control and Complicatons Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993:329(14):977–86.
  3. Urbach SL, LaFranchi S, Lambert L, Lapidus JA, Daneman D, Becker TM. Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes 2005;6:69–74.
  4. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39(3):481-97.
  5. Daneman D, Wolfson DH, Becker DJ, Drash AL. Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes. J Pediatr 1981;99(6):847–53.
  6. Mortensen HB, Robertson KJ, Aanstoot HJ et al. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Diabet Med 1998;15:752–9.
  7. Jacobson AM, Hauser ST, Willett J, Wolfsdorf JI, Herman L. Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin- dependent diabetes mellitus. J Pediatr 1997;131(5):727–33.
  8. Levine BS, Anderson BJ, Butler DA, Antisde JE, Brackett J, Laffel LM. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr. 2001;139(2):197–203.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

November 28, 2019

Submission Date

September 21, 2019

Acceptance Date

-

Published in Issue

Year 2019 Volume: 19 Number: 4

APA
Kara, Ö. (2019). Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control. Ankara Medical Journal, 19(4), 753-760. https://doi.org/10.17098/amj.651991
AMA
1.Kara Ö. Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control. Ankara Med J. 2019;19(4):753-760. doi:10.17098/amj.651991
Chicago
Kara, Özlem. 2019. “Effect of Baseline Clinical and Laboratory Characteristics of Patients With Type 1 Diabetes Mellitus on Metabolic Control”. Ankara Medical Journal 19 (4): 753-60. https://doi.org/10.17098/amj.651991.
EndNote
Kara Ö (November 1, 2019) Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control. Ankara Medical Journal 19 4 753–760.
IEEE
[1]Ö. Kara, “Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control”, Ankara Med J, vol. 19, no. 4, pp. 753–760, Nov. 2019, doi: 10.17098/amj.651991.
ISNAD
Kara, Özlem. “Effect of Baseline Clinical and Laboratory Characteristics of Patients With Type 1 Diabetes Mellitus on Metabolic Control”. Ankara Medical Journal 19/4 (November 1, 2019): 753-760. https://doi.org/10.17098/amj.651991.
JAMA
1.Kara Ö. Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control. Ankara Med J. 2019;19:753–760.
MLA
Kara, Özlem. “Effect of Baseline Clinical and Laboratory Characteristics of Patients With Type 1 Diabetes Mellitus on Metabolic Control”. Ankara Medical Journal, vol. 19, no. 4, Nov. 2019, pp. 753-60, doi:10.17098/amj.651991.
Vancouver
1.Özlem Kara. Effect of Baseline Clinical and Laboratory Characteristics of Patients with Type 1 Diabetes Mellitus on Metabolic Control. Ankara Med J. 2019 Nov. 1;19(4):753-60. doi:10.17098/amj.651991